What molecular mechanisms mediate HDAC9's effects on Aβ deposition and synaptic function?

PARTIALLY ADDRESSED

The abstract shows HDAC9 overexpression reduces Aβ deposition and improves synaptic deficits, but the underlying molecular pathways are not explained. Understanding these mechanisms is critical for developing HDAC9-targeted therapeutics for AD. Gap type: unexplained_observation Source paper: Neuronal HDAC9: A key regulator of cognitive and synaptic aging, rescuing Alzheimer's disease-related phenotypes. (2026, Mol Psychiatry, PMID:41935184)

Priority: 0.89 Domain: neurodegeneration Hypotheses: 0

📊 Landscape Analysis

Landscape Summary: What molecular mechanisms mediate HDAC9's effects on Aβ deposition and synaptic function? is a 0.89 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.

Key Unanswered Questions

What is the optimal TREM2 modulation strategy across disease stages?
How does DAM activation state affect therapeutic outcomes?
What biomarkers predict response to TREM2-targeted interventions?

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

What molecular mechanisms mediate HDAC9's effects on Aβ deposition and synaptic function? — INVOKE-2 (completed)

📈 Living Dashboards

0

Hypotheses

0.000

Top Score

0.000

Avg Score

0

Debates

0.00

Avg Quality

60%

Resolution

0

Mechanistic Families

Gap Resolution Progress60%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

Metabolic Reprogramming of SPP1-Activated Microglia

Target: HK2 Pathway: N/A

0.000

score

CD44-SPP1 Axis Precision Targeting

Target: CD44 Pathway: N/A

0.000

score

SPP1-Integrin Competitive Inhibition

Target: ITGAV Pathway: N/A

0.000

score

Complement-Independent SPP1 Signaling Disruption

Target: RHOA Pathway: N/A

0.000

score

Perivascular Cell Reprogramming via CREB Inhibition

Target: CREB1 Pathway: N/A

0.000

score

Epigenetic Silencing of SPP1 in Disease-Associated Microglia

Target: HDAC1 Pathway: N/A

0.000

score

🌊 Knowledge Graph Connections

activates (11)

HDAC9→StrokeHDAC9→AtherosclerosisHDAC9→InflammationMETTL3→HDAC9HDAC→HDAC9

▸ Show 6 more

HDAC9→NANOGAND→HDAC9HDAC9→INFLAMMATIONHDAC9→POU5F1HDAC9→KDRHDAC5→HDAC9

associated with (17)

MEF2D→HDAC9HDAC9→MEF2HDAC9→HDAC3HDAC9→AlsHDAC9→Coronary Artery Disease

▸ Show 12 more

HDAC9→StrokeHDAC9→InflammationHDAC9→INFLAMMATIONMMP12→HDAC9HDAC9→GENESHDAC9→RUNX2PERICYTE→HDAC9HDAC5→HDAC9ATM→HDAC9HDAC9→APOEHDAC9→ALDH2HDAC9→STROKE

causes (2)

HDAC9→InflammationINFLAMMATION→HDAC9

expressed in (1)

HDAC9→neurons

inhibits (2)

HDAC9→NFKB1HDAC5→HDAC9

interacts with (2)

HDAC9→MEF2CHDAC9→HDAC3

participates in (2)

HDAC9→epigenetic regulationHDAC9→oxidative stress response

protective against (2)

HDAC9→cognitive functionHDAC9→Alzheimer's disease

recruits (1)

regulates (6)

HDAC9→MEF2CHDAC9→ARCHDAC9→BDNFHDAC9→synaptic gene expressionHDAC3→HDAC9

▸ Show 1 more

represses (1)

HDAC9→MEF2 target genes

requires (2)

HDAC9→nuclear accumulationHDAC9→nuclear import

therapeutic target (1)

🕑 Activity Feed

📈 Perivascular Cell Reprogramming via CREB Inhibition score=0.000 2026-04-28T22:03

📈 Metabolic Reprogramming of SPP1-Activated Microglia score=0.000 2026-04-28T22:01

📈 CD44-SPP1 Axis Precision Targeting score=0.000 2026-04-28T22:01

📈 SPP1-Integrin Competitive Inhibition score=0.000 2026-04-28T22:01

📈 Complement-Independent SPP1 Signaling Disruption score=0.000 2026-04-28T22:01

✏ update on knowledge_gap by max_outlook1 2026-04-28T01:37

✏ update on knowledge_gap by None 2026-04-25T22:15

✏ update on knowledge_gap by None 2026-04-15T09:41

✏ update on knowledge_gap by None 2026-04-15T09:41

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

Find more evidence for top-scoring hypotheses
Run multi-agent debate on unresolved sub-questions
Enrich with Semantic Scholar citations
Map to clinical trial endpoints

← Back to All Gaps